Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leslie M Randall

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 12, 2020
Prevalence and predictors of HIV screening in invasive cervical cancer: a 10 year cohort studyJill Alldredge, Marie-Claire Leaf, Priya Patel, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 24, 2011
Differentiating squamous cell carcinoma of the cervix and epithelioid trophoblastic tumorSara Jordan, Leslie M Randall, Yevgeniy Karamurzin, et al.
Gynecologic Oncology|November 19, 2023
Cervical cancer treatment update: A Society of Gynecologic Oncology clinical practice statementEugenia Girda, Leslie M Randall, Fumiko Chino, et al.
Gynecologic Oncology|December 6, 2011
Predictive value of serum CA-125 levels in patients with persistent or recurrent epithelial ovarian cancer or peritoneal cancer treated with bevacizumab on a Gynecologic Oncology Group phase II trialLeslie M Randall, Michael W Sill, Robert A Burger, et al.
American Journal of Obstetrics and Gynecology|March 18, 2011
Fertility preserving options in patients with gynecologic malignanciesRamez N Eskander, Leslie M Randall, Michael L Berman, et al.
Gynecologic Oncology|April 28, 2015
Socioeconomic status as a predictor of adherence to treatment guidelines for early-stage ovarian cancerMelissa Hodeib, Jenny Chang, Fong Liu, et al.
Gynecologic Oncology|September 18, 2010
Prospective evaluation of an in vitro radiation resistance assay in locally advanced cancer of the uterine cervix: a Southwest Oncology Group StudyLeslie M Randall, Bradley J Monk, James Moon, et al.
Archives of Gynecology and Obstetrics|January 29, 2026
Prognostic value of FDG-PET SUV changes in cervical cancer following radiation therapy: a retrospective cohort studyClaudia A Bale, Janina V Pearce, Xiaoyan Deng, et al.
Gynecologic Oncology|December 27, 2008
Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group studyLeslie M Randall, Bradley J Monk, Kathleen M Darcy, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 24, 2015
Expression Patterns of the Wnt Pathway Inhibitors Dickkopf3 and Secreted Frizzled-Related Proteins 1 and 4 in Endometrial Endometrioid Adenocarcinoma: An NRG Oncology/Gynecologic Oncology Group StudyRamez N Eskander, Shamshad Ali, Thanh Dellinger, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 12, 2020
Prevalence and predictors of HIV screening in invasive cervical cancer: a 10 year cohort studyJill Alldredge, Marie-Claire Leaf, Priya Patel, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 24, 2011
Differentiating squamous cell carcinoma of the cervix and epithelioid trophoblastic tumorSara Jordan, Leslie M Randall, Yevgeniy Karamurzin, et al.
Gynecologic Oncology|November 19, 2023
Cervical cancer treatment update: A Society of Gynecologic Oncology clinical practice statementEugenia Girda, Leslie M Randall, Fumiko Chino, et al.
Gynecologic Oncology|December 6, 2011
Predictive value of serum CA-125 levels in patients with persistent or recurrent epithelial ovarian cancer or peritoneal cancer treated with bevacizumab on a Gynecologic Oncology Group phase II trialLeslie M Randall, Michael W Sill, Robert A Burger, et al.
American Journal of Obstetrics and Gynecology|March 18, 2011
Fertility preserving options in patients with gynecologic malignanciesRamez N Eskander, Leslie M Randall, Michael L Berman, et al.
Gynecologic Oncology|April 28, 2015
Socioeconomic status as a predictor of adherence to treatment guidelines for early-stage ovarian cancerMelissa Hodeib, Jenny Chang, Fong Liu, et al.
Gynecologic Oncology|September 18, 2010
Prospective evaluation of an in vitro radiation resistance assay in locally advanced cancer of the uterine cervix: a Southwest Oncology Group StudyLeslie M Randall, Bradley J Monk, James Moon, et al.
Archives of Gynecology and Obstetrics|January 29, 2026
Prognostic value of FDG-PET SUV changes in cervical cancer following radiation therapy: a retrospective cohort studyClaudia A Bale, Janina V Pearce, Xiaoyan Deng, et al.
Gynecologic Oncology|December 27, 2008
Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group studyLeslie M Randall, Bradley J Monk, Kathleen M Darcy, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 24, 2015
Expression Patterns of the Wnt Pathway Inhibitors Dickkopf3 and Secreted Frizzled-Related Proteins 1 and 4 in Endometrial Endometrioid Adenocarcinoma: An NRG Oncology/Gynecologic Oncology Group StudyRamez N Eskander, Shamshad Ali, Thanh Dellinger, et al.
Pageof 6